RYAN ARTHUR F
SEC CIK 1187443 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 17.3K | — | $9.67M | 50 | 2021-07-01 | 2026-07-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
Transactions 50
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-07 16:05 | 2026-07-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $650.15 | -200 | 17.3K | -1% | -$130.0K |
| MT | 2026-05-04 16:14 | 2026-05-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $705.24 | -100 | 17.5K | -0.6% | -$70.5K |
| MT | 2026-04-03 16:01 | 2026-04-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $777.27 | -100 | 17.6K | -0.6% | -$77.7K |
| M | 2026-03-03 | 2026-03-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $785.50 | -100 | 17.8K | -0.6% | -$78.5K |
| M | 2026-02-11 | 2026-02-09 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $778.53 | -100 | 17.9K | -0.6% | -$77.9K |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +155 | 17.9K | +0.9% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +166 | 17.7K | +0.9% | $0 |
| M | 2024-10-03 | 2024-10-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $1,048.78 | -100 | 17.6K | -0.6% | -$104.9K |
| M | 2024-09-05 | 2024-09-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $1,178.68 | -100 | 17.7K | -0.6% | -$117.9K |
| 2024-08-05 | 2024-08-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $1,100.03 | -1 | 17.8K | -0.0% | -$1,100 | |
| M | 2024-08-05 | 2024-08-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $1,085.53 | -99 | 17.8K | -0.6% | -$107.5K |
| M | 2024-07-02 | 2024-07-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $1,059.24 | -100 | 17.9K | -0.6% | -$105.9K |
| M | 2024-06-05 | 2024-06-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $994.50 | -100 | 18.1K | -0.6% | -$99.4K |
| M | 2024-05-03 | 2024-05-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $899.61 | -100 | 18.2K | -0.5% | -$90.0K |
| M | 2024-04-03 | 2024-04-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $962.53 | -100 | 18.3K | -0.5% | -$96.3K |
| M | 2024-03-05 | 2024-03-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $982.05 | -100 | 18.4K | -0.5% | -$98.2K |
| M | 2024-02-05 | 2024-02-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $954.22 | -100 | 18.5K | -0.5% | -$95.4K |
| DM | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $899.90 | -100 | 18.4K | -0.5% | -$90.0K |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +135 | 18.5K | +0.7% | $0 |
| M | 2023-12-04 | 2023-12-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $817.30 | -100 | 18.5K | -0.5% | -$81.7K |
| M | 2023-11-08 | 2023-11-07 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $827.90 | -100 | 18.6K | -0.5% | -$82.8K |
| M | 2023-08-03 | 2023-08-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $736.59 | -100 | 18.7K | -0.5% | -$73.7K |
| M | 2023-07-06 | 2023-07-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $716.88 | -100 | 18.7K | -0.5% | -$71.7K |
| M | 2023-06-02 | 2023-06-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $735.42 | -100 | 18.9K | -0.5% | -$73.5K |
| M | 2023-05-03 | 2023-05-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $805.33 | -100 | 19.0K | -0.5% | -$80.5K |
| M | 2023-04-05 | 2023-04-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $819.31 | -100 | 19.1K | -0.5% | -$81.9K |
| M | 2023-03-03 | 2023-03-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $762.50 | -100 | 19.2K | -0.5% | -$76.2K |
| M | 2023-02-03 | 2023-02-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $756.13 | -100 | 19.2K | -0.5% | -$75.6K |
| DM | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $726.29 | -100 | 19.3K | -0.5% | -$72.6K |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +165 | 19.3K | +0.9% | $0 |
| M | 2022-12-02 | 2022-12-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $758.17 | -100 | 19.3K | -0.5% | -$75.8K |
| M | 2022-11-03 | 2022-11-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $755.89 | -100 | 19.4K | -0.5% | -$75.6K |
| M | 2022-10-05 | 2022-10-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $726.54 | -100 | 19.5K | -0.5% | -$72.7K |
| M | 2022-09-08 | 2022-09-06 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $582.37 | -100 | 19.6K | -0.5% | -$58.2K |
| DM | 2022-08-08 | 2022-08-04 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale+OE | $621.29 | -10.5K | 18.4K | -36% | -$6.49M |
| DM | 2022-08-08 | 2022-08-04 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | M - OptEx | $413.26 | +10.5K | 23.3K | +81% | +$4.32M |
| D | 2022-08-08 | 2022-08-04 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | G - Gift | $0.00 | -2,500 | 19.7K | -11% | $0 |
| M | 2022-05-03 | 2022-05-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $650.78 | -100 | 22.3K | -0.4% | -$65.1K |
| M | 2022-04-04 | 2022-04-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $692.81 | -100 | 22.3K | -0.4% | -$69.3K |
| M | 2022-03-03 | 2022-03-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $618.37 | -100 | 22.5K | -0.4% | -$61.8K |
| M | 2022-02-02 | 2022-02-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $607.14 | -100 | 22.6K | -0.4% | -$60.7K |
| DM | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $624.95 | -100 | 22.5K | -0.4% | -$62.5K |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +191 | 22.6K | +0.9% | $0 |
| M | 2021-12-02 | 2021-12-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $637.53 | -100 | 22.6K | -0.4% | -$63.8K |
| 2021-12-02 | 2021-11-16 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | G - Gift | $0.00 | -500 | 22.6K | -2% | $0 | |
| M | 2021-11-03 | 2021-11-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $642.52 | -100 | 23.1K | -0.4% | -$64.3K |
| M | 2021-10-04 | 2021-10-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $569.49 | -100 | 23.3K | -0.4% | -$56.9K |
| M | 2021-09-03 | 2021-09-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $676.28 | -100 | 23.3K | -0.4% | -$67.6K |
| M | 2021-08-04 | 2021-08-02 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $577.95 | -100 | 23.5K | -0.4% | -$57.8K |
| M | 2021-07-02 | 2021-07-01 | REGN | Regeneron Pharmaceuticals | RYAN ARTHUR F | Dir | S - Sale | $564.50 | -100 | 23.5K | -0.4% | -$56.5K |
Purchase Sale Sale after option exercise All abbreviations